Hematologic Malignancies

Clinical Trials & Studies

Investigational Therapy to Reprogram Patient’s Immune Response to Cancer Cells

First-in-Human Trial of GEN3009 in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Research resources we offer for clinicians in the field of hematologic malignancies include the following:

  • Innovations in Clinical Trials: This publication highlights the work of clinicians and researchers at UH who are making significant strides in the treatment of hematologic malignancies.
  • Physician research publications: Our physicians are dedicated to advancing care for hematologic malignancies through leading-edge research studies. Read more about the published work of our physician-scientists.